The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain - Wikidata - awgldk - TriplyDB

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

http://www.wikidata.org/entity/Q28281433

about

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Receptors for acylethanolamides-GPR55 and GPR119 Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay Lysophosphatidylinositol Signalling and Metabolic Diseases Cannabinoids and Epilepsy.What we know and do not know about the cannabinoid receptor 2 (CB2)CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination.Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability Pharmacological characterization of GPR55, a putative cannabinoid receptor Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside GPR55 ligands promote receptor coupling to multiple signalling pathways.The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment Novel lysophosphoplipid receptors: their structure and function.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.The endocannabinoid system and pain Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.NEURONAL DEVELOPMENT. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord.The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray Molecular Targets of Cannabidiol in Neurological Disorders Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum IgE levels in immunized mice.Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.Nicotinic acetylcholine receptors modulate osteoclastogenesis Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones A potential role for GPR55 in gastrointestinal functions

P2860

Q24311776-3BC19C6A-2F3C-4233-BAC6-4D6928FC76B0 Q24322122-E291701F-7C36-4337-8FA8-D78A3D31F99F Q24647538-D6168B2F-EAC6-44EF-AC08-D9E1E5D99404 Q24654730-9D01A6D0-5865-4ADD-BADC-76FF4CA4AE88 Q26771102-8EE8A522-F6F2-4560-8F60-E92DEE035650 Q27336451-5AA161E4-6FA6-47B7-944B-FEB0AFA925E4 Q27686851-2A3B18C0-9B6A-4E7C-8568-FD306A6005E9 Q28072822-E9E72B36-BE99-413B-B8E4-8CB6B1DC24BA Q28286551-DAB9A56B-0C02-45FE-8A85-E4473F03D3CA Q28303095-9D93728F-2DDE-4102-937A-9857DD01ACD3 Q28508581-96D75B39-CEA3-4CF4-B4CA-5528203DC5EB Q33636763-FF7DD644-947B-4BAA-B3B8-AE1309A2CED8 Q33681317-C4BDC9E0-A2F6-4163-9EA4-8FCE4C7D8964 Q33751118-329CE487-7EDC-4BC6-9D3F-5DA09EAF41FC Q33869340-ED75F8E3-36CC-4FDF-9D34-2B5A3F7D1CFD Q33887246-AB872AAD-6773-435A-BC16-28D2008C4818 Q34019573-E00369E9-42FA-4A42-A1C6-FC3BD1B64639 Q34098246-A05CAA7F-60C0-473E-8CEF-8B0AF0771089 Q34199383-78F8837D-7FEB-4CB8-A7A9-E2D30B876844 Q34238610-CA1A53F5-22BC-4F96-9218-0352EAF001E7 Q34403197-C0AEB9F3-322F-4AE2-8F7B-D7BF0B82592F Q34453695-0D2C7D31-4C0A-4171-8C2F-60B2CA418371 Q34612917-D82AC3E2-ED2A-4498-B4BE-7E567C6DF350 Q34953430-8C209FD2-312A-4A94-860D-72C9E8E5052C Q35018622-7492FB3A-6FA3-4600-9335-69E961C3E802 Q35052556-5DD2B29E-16D8-4668-B516-496F64F79FF5 Q35602343-0F781FAB-BE5D-4DE3-A577-1F4FBD81A254 Q35643909-B9F4D88C-3AE7-4AC7-9460-FB08F59BD862 Q35674014-164DA647-9234-4751-A21F-00918BC68AD9 Q35696499-ACFF1588-CD75-480A-A406-C1737CD7836E Q35758062-384A3555-6FBE-4A37-9C24-F9A444AF09A4 Q35897858-F7BBD5BC-078B-461C-A00C-9A7EC3A1588C Q36157649-2103824C-41B3-4F29-8046-8FC97B032C87 Q36166294-CBB65E69-31FC-4C74-9444-5A7690F43B24 Q36219994-5123AFF7-4BFB-483D-9F67-1B52D07161E8 Q36398022-A9A7C35F-CA24-4BB7-8C47-42D25356469A Q36492788-11186BE0-9BCA-45E5-9970-CFB3F704A1E1 Q36680435-8106EBF7-F520-4B3A-AADF-A3497CE31148 Q36811111-0021665B-D6F0-42BE-873C-8FDEA621DC6D Q36864469-83F5B489-E27C-4694-939C-1ACC126FFB0B

P2860

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

http://www.wikidata.org/entity/Q28281433

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The putative cannabinoid recep ...... lammatory and neuropathic pain

@ast

The putative cannabinoid recep ...... lammatory and neuropathic pain

@en

The putative cannabinoid recep ...... lammatory and neuropathic pain

@nl

type

label

The putative cannabinoid recep ...... lammatory and neuropathic pain

@ast

The putative cannabinoid recep ...... lammatory and neuropathic pain

@en

The putative cannabinoid recep ...... lammatory and neuropathic pain

@nl

prefLabel

The putative cannabinoid recep ...... lammatory and neuropathic pain

@ast

The putative cannabinoid recep ...... lammatory and neuropathic pain

@en

The putative cannabinoid recep ...... lammatory and neuropathic pain

@nl

P1433

Q28281433-9FB9D6A5-C3DB-43CD-8855-1045E14216DC

P1476

Q28281433-6255B96E-A7F0-4496-8931-A5B47AF0F492

P2093

Q28281433-275123C5-FD13-4575-937D-7A0EA94206E5

Q28281433-2BA26A14-7607-4AA0-8BBF-79972A1862C2

Q28281433-31295829-6C1D-4196-8264-157852407213

Q28281433-44625741-53AB-4371-ADB1-48904A46E827

Q28281433-55201592-EC95-4DBF-B194-982E3094B320

Q28281433-55986AD4-153A-458B-A00D-A78497E32F9F

Q28281433-5AB1899D-2478-4FEE-8DB0-F5725C657BAF

Q28281433-61E2A057-209E-446F-AD8A-5D2D271551B7

Q28281433-6B760793-97F3-4860-A39E-BA1963040FF1

Q28281433-6CA1AD23-BB3D-451C-AF48-20937EB00651

P304

Q28281433-D2A209E6-B299-4A65-B96B-D5C6EE3AAE5F

P31

Q28281433-5D67230A-144E-4C40-B446-BCF40AC278AE

P3181

Q28281433-D4516C59-AAC1-4056-AFC8-1A95DC9A3FB2

P356

Q28281433-BCB1342E-4EFB-43FB-8896-B54420C0EAEC

P407

Q28281433-57A397BB-8EB8-4321-BC28-EBBA60ED2BD6

P433

Q28281433-9053649A-ACE1-4E1D-AD46-6DA683EF070B

P478

Q28281433-62D6D377-1B37-48F2-B39A-F0AB94C0B9AD

P50

Q28281433-11C8BE82-836C-47D5-8F0E-F4B2D8E726D7

P577

Q28281433-60B920B6-9C79-4296-8DAC-5CB0C60E9A76

P5875

Q28281433-45BD1141-FC6D-4639-89CE-AA915C1FD616

P698

Q28281433-D277C4F7-121B-4626-BB95-6032489BC188

P921

Q28281433-07FFB6DB-9265-4EAA-A253-4D4269CD573F

Q28281433-A373EE21-BCA9-4E6B-80AC-526610D48258

Q28281433-B8A3DA8A-13BA-402E-A528-49B4E2038399

Q28281433-E77930E9-6957-4983-AE5E-383CE6F6B265

Q28281433-a52d70c7-b475-41df-9a28-e24a20c3e9ca

P3181

P356

J.PAIN.2008.04.006

P1433

P1476

The putative cannabinoid recep ...... lammatory and neuropathic pain

@en

P2093

Alan Wise

http://www.w3.org/2001/XMLSchema#string

Alastair D Morrison

http://www.w3.org/2001/XMLSchema#string

Andy Billinton

http://www.w3.org/2001/XMLSchema#string

Deborah J Walker

http://www.w3.org/2001/XMLSchema#string

Elizabeth Chong

http://www.w3.org/2001/XMLSchema#string

Ellen M Shapland

http://www.w3.org/2001/XMLSchema#string

Hilary C Lancaster

http://www.w3.org/2001/XMLSchema#string

Iain P Chessell

http://www.w3.org/2001/XMLSchema#string

Jane P Hughes

http://www.w3.org/2001/XMLSchema#string

Jason C Smith

http://www.w3.org/2001/XMLSchema#string

P304

225-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3950266

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.PAIN.2008.04.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5346870

http://www.w3.org/2001/XMLSchema#string

P698

18502582

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

cannabinoid receptor